Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Giardia lamblia | Mevalonate kinase | 0.0118 | 0.1576 | 0.5 |
Echinococcus multilocularis | N acetylgalactosamine kinase | 0.018 | 0.3511 | 0.2298 |
Brugia malayi | galactokinase family protein | 0.018 | 0.3511 | 1 |
Mycobacterium leprae | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0118 | 0.1576 | 0.5 |
Trypanosoma cruzi | galactokinase, putative | 0.0386 | 1 | 1 |
Schistosoma mansoni | galactokinase | 0.018 | 0.3511 | 1 |
Trypanosoma brucei | galactokinase-like protein, putative | 0.0256 | 0.5923 | 1 |
Mycobacterium ulcerans | galactokinase | 0.0386 | 1 | 1 |
Toxoplasma gondii | GHMP kinase, N-terminal domain-containing protein | 0.018 | 0.3511 | 1 |
Trichomonas vaginalis | galactokinase, putative | 0.018 | 0.3511 | 1 |
Mycobacterium tuberculosis | Probable galactokinase GalK (galactose kinase) | 0.0386 | 1 | 1 |
Trypanosoma cruzi | homoserine kinase | 0.0118 | 0.1576 | 0.1576 |
Trichomonas vaginalis | galactokinase, putative | 0.018 | 0.3511 | 1 |
Trypanosoma cruzi | homoserine kinase | 0.0118 | 0.1576 | 0.1576 |
Entamoeba histolytica | galactokinase, putative | 0.0386 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0118 | 0.1576 | 0.5 |
Trypanosoma cruzi | galactokinase, putative | 0.0336 | 0.8424 | 0.8424 |
Trypanosoma cruzi | galactokinase-like protein, putative | 0.0336 | 0.8424 | 0.8424 |
Echinococcus granulosus | N acetylgalactosamine kinase | 0.018 | 0.3511 | 0.2298 |
Trypanosoma cruzi | mevalonate kinase, putative | 0.0118 | 0.1576 | 0.1576 |
Echinococcus multilocularis | galactokinase | 0.0386 | 1 | 1 |
Loa Loa (eye worm) | galactokinase | 0.018 | 0.3511 | 1 |
Trypanosoma cruzi | galactokinase, putative | 0.0386 | 1 | 1 |
Trichomonas vaginalis | galactokinase, putative | 0.018 | 0.3511 | 1 |
Leishmania major | galactokinase-like protein | 0.0386 | 1 | 1 |
Trichomonas vaginalis | galactokinase, putative | 0.018 | 0.3511 | 1 |
Treponema pallidum | galactokinase | 0.0336 | 0.8424 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.